Back Pain Lower Back Completed Phase 3 Trials for Tapentadol (DB06204)

Also known as: Low Back Pain (LBP) / Lumbago / Lumbar Pain / Lower Back Pain / Low Back Pain / Low Back Ache / Low-Back Pain / Pains, Low Back / Loin pain / Lumbalgia / Pain back / Back pain / Pain dorsal / Back ache / Backache / Pain over the back / Backache, unspecified / Dorsal pain / Dorsalgia

IndicationStatusPhase
DBCOND0041441 (Back Pain Lower Back)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00361504A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic PainTreatment
NCT00983385Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular AnalgesicsTreatment
NCT00986180NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back PainTreatment
NCT00594516Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back PainTreatment
NCT00487435An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic PainTreatment
NCT00449176A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back PainTreatment
NCT00364546A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic PainTreatment